These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30328212)

  • 1. Analysis of the TTR gene in the investigation of amyloidosis: A 25-year single UK center experience.
    Rowczenio D; Quarta CC; Fontana M; Whelan CJ; Martinez-Naharro A; Trojer H; Baginska A; Ferguson SM; Gilbertson J; Rezk T; Sachchithanantham S; Mahmood S; Manwani R; Sharpley F; Wechalekar AD; Hawkins PN; Gillmore JD; Lachmann HJ
    Hum Mutat; 2019 Jan; 40(1):90-96. PubMed ID: 30328212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).
    Ruberg FL; Maurer MS; Judge DP; Zeldenrust S; Skinner M; Kim AY; Falk RH; Cheung KN; Patel AR; Pano A; Packman J; Grogan DR
    Am Heart J; 2012 Aug; 164(2):222-228.e1. PubMed ID: 22877808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR).
    Phull P; Sanchorawala V; Connors LH; Doros G; Ruberg FL; Berk JL; Sarosiek S
    Amyloid; 2018 Mar; 25(1):62-67. PubMed ID: 29424556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS).
    Bhuiyan T; Helmke S; Patel AR; Ruberg FL; Packman J; Cheung K; Grogan D; Maurer MS
    Circ Heart Fail; 2011 Mar; 4(2):121-8. PubMed ID: 21191093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy.
    Porcari A; Razvi Y; Masi A; Patel R; Ioannou A; Rauf MU; Hutt DF; Rowczenio D; Gilbertson J; Martinez-Naharro A; Venneri L; Whelan C; Lachmann H; Wechalekar A; Quarta CC; Merlo M; Sinagra G; Hawkins PN; Fontana M; Gillmore JD
    Eur J Heart Fail; 2023 Apr; 25(4):515-524. PubMed ID: 36644836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Proteomic Profiling in Inherited (ATTRm) and Acquired (ATTRwt) Forms of Transthyretin-Associated Cardiac Amyloidosis.
    Chan GG; Koch CM; Connors LH
    J Proteome Res; 2017 Apr; 16(4):1659-1668. PubMed ID: 28196416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation of the transthyretin gene in wild-type transthyretin amyloidosis (ATTRwt).
    Sikora JL; Logue MW; Chan GG; Spencer BH; Prokaeva TB; Baldwin CT; Seldin DC; Connors LH
    Hum Genet; 2015 Jan; 134(1):111-21. PubMed ID: 25367359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.
    Connors LH; Prokaeva T; Lim A; Théberge R; Falk RH; Doros G; Berg A; Costello CE; O'Hara C; Seldin DC; Skinner M
    Am Heart J; 2009 Oct; 158(4):607-14. PubMed ID: 19781421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted sequencing of selected functional genes in patients with wild-type transthyretin amyloidosis.
    Moreno-Gázquez I; Pérez-Palacios R; Abengochea-Quílez L; Lahuerta Pueyo C; Roteta Unceta Barrenechea A; Andrés Gracia A; Aibar Arregui MA; Menao Guillén S
    BMC Res Notes; 2023 Oct; 16(1):249. PubMed ID: 37784196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diflunisal tolerability in transthyretin cardiac amyloidosis: a single center's experience.
    Ikram A; Donnelly JP; Sperry BW; Samaras C; Valent J; Hanna M
    Amyloid; 2018 Sep; 25(3):197-202. PubMed ID: 30388377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Amyloidosis Due to Transthyretin Protein: A Review.
    Ruberg FL; Maurer MS
    JAMA; 2024 Mar; 331(9):778-791. PubMed ID: 38441582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?
    Razvi Y; Ioannou A; Patel RK; Chacko L; Karia N; Riefolo M; Porcari A; Rauf MU; Starr N; Ganesananthan S; Blakeney I; Kaza N; Filisetti S; Bolhuis RE; Rowczenio D; Gilbertson J; Hutt D; Mahmood S; Lachmann HJ; Wechalekar AD; Kotecha T; Knight DS; Coghlan JG; Petrie A; Whelan CJ; Venneri L; Martinez-Naharro A; Hawkins P; Fontana M; Gillmore JD
    Eur J Heart Fail; 2024 Feb; 26(2):383-393. PubMed ID: 37953725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transthyretin: Its function and amyloid formation.
    Ueda M
    Neurochem Int; 2022 May; 155():105313. PubMed ID: 35218869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan.
    Ueda M; Yamashita T; Misumi Y; Masuda T; Ando Y
    Amyloid; 2018 Sep; 25(3):143-147. PubMed ID: 30486687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial.
    Waddington-Cruz M; Ackermann EJ; Polydefkis M; Heitner SB; Dyck PJ; Barroso FA; Wang AK; Berk JL; Dyck PJB; Monia BP; Hughes SG; Tai L; Jesse Kwoh T; Jung SW; Coelho T; Benson MD; Gertz MA
    Amyloid; 2018 Sep; 25(3):180-188. PubMed ID: 30169969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and Treatment Approaches Involving Transthyretin in Amyloidogenic Diseases.
    Park GY; Jamerlan A; Shim KH; An SSA
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.
    Rapezzi C; Merlini G; Quarta CC; Riva L; Longhi S; Leone O; Salvi F; Ciliberti P; Pastorelli F; Biagini E; Coccolo F; Cooke RM; Bacchi-Reggiani L; Sangiorgi D; Ferlini A; Cavo M; Zamagni E; Fonte ML; Palladini G; Salinaro F; Musca F; Obici L; Branzi A; Perlini S
    Circulation; 2009 Sep; 120(13):1203-12. PubMed ID: 19752327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
    Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
    Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenome-wide association study of TTR and RBP4 genes in 361,194 individuals reveals novel insights in the genetics of hereditary and wildtype transthyretin amyloidoses.
    De Lillo A; De Angelis F; Di Girolamo M; Luigetti M; Frusconi S; Manfellotto D; Fuciarelli M; Polimanti R
    Hum Genet; 2019 Dec; 138(11-12):1331-1340. PubMed ID: 31659433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
    Sekijima Y
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.